Incyte (INCY) Non-Current Deferred Tax Liability (2013 - 2015)
Incyte (INCY) reported Non-Current Deferred Tax Liability of $9.7 million for Q3 2015, up 1153.16% on a YoY basis from $775000.0 in Q3 2014, and up 25.72% quarter-over-quarter from $7.7 million in Q2 2015.
Incyte (INCY) Non-Current Deferred Tax Liability (2013 - 2015) Analysis & Trends
Incyte has reported Non-Current Deferred Tax Liability for 3 years, with the latest figure at $9.7 million in Q3 2015.
- For the quarter ending Q3 2015, Non-Current Deferred Tax Liability rose 1153.16% year-over-year to $9.7 million; the trailing twelve-month figure through Sep 2015 stood at $9.7 million (up 1153.16% YoY), and the FY2014 full-year result was $19.6 million, up 2094.53% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2015 stood at $9.7 million, up from $7.7 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $19.6 million in Q4 2014, with the low at $775000.0 in Q3 2014.
- Historically, Non-Current Deferred Tax Liability has averaged $5.8 million across 3 years, with a median of $3.5 million in 2014.
- Annual changes were most pronounced in 2014 — Non-Current Deferred Tax Liability surged 2094.53% — and 2015, when it jumped 575.45%.
- Incyte's Non-Current Deferred Tax Liability stood at $895000.0 in 2013, then surged by 2094.53% to $19.6 million in 2014, then sank by 50.55% to $9.7 million in 2015.
- The last three Non-Current Deferred Tax Liability figures came in at $9.7 million (Q3 2015), $7.7 million (Q2 2015), and $6.0 million (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 9.71 Mn |
| Sep 30, 2015 | 9.71 Mn |
| Jun 30, 2015 | 7.73 Mn |
| Jun 30, 2015 | 7.73 Mn |
| Mar 31, 2015 | 6.03 Mn |
| Mar 31, 2015 | 6.03 Mn |
| Dec 31, 2014 | 19.64 Mn |
| Dec 31, 2014 | 19.64 Mn |
| Sep 30, 2014 | 775,000.00 |
| Sep 30, 2014 | 775,000.00 |
| Jun 30, 2014 | 900,000.00 |
| Jun 30, 2014 | 900,000.00 |
| Mar 31, 2014 | 892,000.00 |
| Mar 31, 2014 | 892,000.00 |
| Dec 31, 2013 | 895,000.00 |
| Dec 31, 2013 | 895,000.00 |